Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.

Scharf EL, Graff-Radford J, Przybelski SA, Lesnick TG, Mielke MM, Knopman DS, Preboske GM, Schwarz CG, Senjem ML, Gunter JL, Machulda M, Kantarci K, Petersen RC, Jack CR Jr, Vemuri P.

Stroke. 2019 Sep 12:STROKEAHA119025822. doi: 10.1161/STROKEAHA.119.025822. [Epub ahead of print]

PMID:
31510903
2.

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes.

Jack CR, Wiste HJ, Botha H, Weigand SD, Therneau TM, Knopman DS, Graff-Radford J, Jones DT, Ferman TJ, Boeve BF, Kantarci K, Lowe VJ, Vemuri P, Mielke MM, Fields JA, Machulda MM, Schwarz CG, Senjem ML, Gunter JL, Petersen RC.

Brain. 2019 Sep 9. pii: awz268. doi: 10.1093/brain/awz268. [Epub ahead of print]

PMID:
31501889
3.

Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia.

Utianski RL, Botha H, Martin PR, Schwarz CG, Duffy JR, Clark HM, Machulda MM, Butts AM, Lowe VJ, Jack CR Jr, Senjem ML, Spychalla AJ, Whitwell JL, Josephs KA.

Brain Lang. 2019 Oct;197:104676. doi: 10.1016/j.bandl.2019.104676. Epub 2019 Aug 13.

PMID:
31419589
4.

An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.

Whitwell JL, Stevens CA, Duffy JR, Clark HM, Machulda MM, Strand EA, Martin PR, Utianski RL, Botha H, Spychalla AJ, Senjem ML, Schwarz CG, Jack CR Jr, Ali F, Hassan A, Josephs KA.

Mov Disord Clin Pract. 2019 May 29;6(6):452-461. doi: 10.1002/mdc3.12796. eCollection 2019 Jul.

PMID:
31392246
5.

Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework.

Jack CR Jr, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P, Lowe VJ, Mielke MM, Roberts RO, Machulda MM, Graff-Radford J, Jones DT, Schwarz CG, Gunter JL, Senjem ML, Rocca WA, Petersen RC.

JAMA Neurol. 2019 Jul 15. doi: 10.1001/jamaneurol.2019.1971. [Epub ahead of print]

6.

Multimodal neuroimaging relationships in progressive supranuclear palsy.

Sintini I, Schwarz CG, Senjem ML, Reid RI, Botha H, Ali F, Ahlskog JE, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL.

Parkinsonism Relat Disord. 2019 Jul 2. pii: S1353-8020(19)30291-3. doi: 10.1016/j.parkreldis.2019.07.001. [Epub ahead of print]

PMID:
31279635
7.

Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia.

Jack CR Jr, Wiste HJ, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Lowe VJ, Vemuri P, Machulda MM, Schwarz CG, Gunter JL, Senjem ML, Graff-Radford J, Jones DT, Roberts RO, Rocca WA, Petersen RC.

JAMA. 2019 Jun 18;321(23):2316-2325. doi: 10.1001/jama.2019.7437.

PMID:
31211344
8.

White matter hyperintensities: relationship to amyloid and tau burden.

Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, Gunter JL, Senjem ML, Przybelski SA, Lesnick T, Ward C, Mielke MM, Lowe VJ, Petersen RC, Kremers WK, Kantarci K, Jack CR, Vemuri P.

Brain. 2019 Aug 1;142(8):2483-2491. doi: 10.1093/brain/awz162.

PMID:
31199475
9.

Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome.

Tetzloff KA, Duffy JR, Clark HM, Utianski RL, Strand EA, Machulda MM, Botha H, Martin PR, Schwarz CG, Senjem ML, Reid RI, Gunter JL, Spychalla AJ, Knopman DS, Petersen RC, Jack CR, Lowe VJ, Josephs KA, Whitwell JL.

Brain. 2019 Aug 1;142(8):2466-2482. doi: 10.1093/brain/awz157.

PMID:
31199471
10.

Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.

Lowe VJ, Lundt ES, Albertson SM, Przybelski SA, Senjem ML, Parisi JE, Kantarci K, Boeve B, Jones DT, Knopman D, Jack CR Jr, Dickson DW, Petersen RC, Murray ME.

Alzheimers Dement. 2019 Jul;15(7):927-939. doi: 10.1016/j.jalz.2019.03.016. Epub 2019 Jun 4.

PMID:
31175025
11.

Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults.

Lowe VJ, Bruinsma TJ, Wiste HJ, Min HK, Weigand SD, Fang P, Senjem ML, Therneau TM, Boeve BF, Josephs KA, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.

Neurology. 2019 Jul 2;93(1):e29-e39. doi: 10.1212/WNL.0000000000007728. Epub 2019 May 30.

PMID:
31147421
12.

Investigation of white matter PiB uptake as a marker of white matter integrity.

Zeydan B, Schwarz CG, Lowe VJ, Reid RI, Przybelski SA, Lesnick TG, Kremers WK, Senjem ML, Gunter JL, Min HK, Vemuri P, Knopman DS, Petersen RC, Jack CR Jr, Kantarci OH, Kantarci K.

Ann Clin Transl Neurol. 2019 Mar 3;6(4):678-688. doi: 10.1002/acn3.741. eCollection 2019 Apr.

13.

Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.

Sintini I, Martin PR, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, Spychalla AJ, Drubach DA, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL.

Neuroimage Clin. 2019;23:101823. doi: 10.1016/j.nicl.2019.101823. Epub 2019 Apr 10.

14.

The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Whitwell JL, Martin P, Graff-Radford J, Machulda MM, Senjem ML, Schwarz CG, Weigand SD, Spychalla AJ, Drubach DA, Jack CR Jr, Lowe VJ, Josephs KA.

Alzheimers Dement. 2019 May;15(5):675-685. doi: 10.1016/j.jalz.2018.12.016. Epub 2019 Mar 8.

PMID:
30853465
15.

Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects.

Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Boeve BF, Jones DT, Graff-Radford J, Albertson SM, Schwarz CG, Petersen RC, Jack CR.

Brain. 2019 Apr 1;142(4):1148-1160. doi: 10.1093/brain/awz025.

PMID:
30759182
16.

Neural correlates of domain-specific cognitive decline: The ARIC-NCS Study.

Schneider ALC, Senjem ML, Wu A, Gross A, Knopman DS, Gunter JL, Schwarz CG, Mosley TH, Gottesman RF, Sharrett AR, Jack CR Jr.

Neurology. 2019 Mar 5;92(10):e1051-e1063. doi: 10.1212/WNL.0000000000007042. Epub 2019 Feb 6.

PMID:
30728308
17.

The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia.

Whitwell JL, Martin PR, Duffy JR, Clark HM, Machulda MM, Schwarz CG, Weigand SD, Sintini I, Senjem ML, Ertekin-Taner N, Botha H, Utianski RL, Graff-Radford J, Jones DT, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA.

Neurology. 2019 Feb 12;92(7):e710-e722. doi: 10.1212/WNL.0000000000006913. Epub 2019 Jan 11.

PMID:
30635491
18.

Cerebral microbleeds: Prevalence and relationship to amyloid burden.

Graff-Radford J, Botha H, Rabinstein AA, Gunter JL, Przybelski SA, Lesnick T, Huston J 3rd, Flemming KD, Preboske GM, Senjem ML, Brown RD Jr, Mielke MM, Roberts RO, Lowe VJ, Knopman DS, Petersen RC, Kremers W, Vemuri P, Jack CR Jr, Kantarci K.

Neurology. 2019 Jan 15;92(3):e253-e262. doi: 10.1212/WNL.0000000000006780. Epub 2018 Dec 19.

PMID:
30568001
19.

Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.

Sintini I, Schwarz CG, Martin PR, Graff-Radford J, Machulda MM, Senjem ML, Reid RI, Spychalla AJ, Drubach DA, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL.

Hum Brain Mapp. 2019 Apr 1;40(5):1618-1631. doi: 10.1002/hbm.24473. Epub 2018 Dec 13.

20.

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.

Schwarz CG, Gunter JL, Lowe VJ, Weigand S, Vemuri P, Senjem ML, Petersen RC, Knopman DS, Jack CR.

J Alzheimers Dis. 2019;67(1):181-195. doi: 10.3233/JAD-180749.

21.

MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.

Whitwell JL, Tosakulwong N, Schwarz CG, Botha H, Senjem ML, Spychalla AJ, Ahlskog JE, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA.

Mov Disord. 2019 Jan;34(1):105-113. doi: 10.1002/mds.27546. Epub 2018 Nov 23.

22.

Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration.

Zeydan B, Tosakulwong N, Schwarz CG, Senjem ML, Gunter JL, Reid RI, Gazzuola Rocca L, Lesnick TG, Smith CY, Bailey KR, Lowe VJ, Roberts RO, Jack CR Jr, Petersen RC, Miller VM, Mielke MM, Rocca WA, Kantarci K.

JAMA Neurol. 2019 Jan 1;76(1):95-100. doi: 10.1001/jamaneurol.2018.3057.

23.

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging.

Vemuri P, Lesnick TG, Przybelski SA, Graff-Radford J, Reid RI, Lowe VJ, Zuk SM, Senjem ML, Schwarz CG, Gunter JL, Kantarci K, Machulda MM, Mielke MM, Petersen RC, Knopman DS, Jack CR Jr.

Ann Neurol. 2018 Nov;84(5):705-716. doi: 10.1002/ana.25346. Epub 2018 Oct 25.

24.

TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.

Sahoo A, Bejanin A, Murray ME, Tosakulwong N, Weigand SD, Serie AM, Senjem ML, Machulda MM, Parisi JE, Boeve BF, Knopman DS, Petersen RC, Dickson DW, Whitwell JL, Josephs KA.

J Alzheimers Dis. 2018;64(4):1227-1233. doi: 10.3233/JAD-180169.

25.

Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.

Nedelska Z, Senjem ML, Przybelski SA, Lesnick TG, Lowe VJ, Boeve BF, Arani A, Vemuri P, Graff-Radford J, Ferman TJ, Jones DT, Savica R, Knopman DS, Petersen RC, Jack CR, Kantarci K.

Neuroimage Clin. 2018 Jun 19;19:939-947. doi: 10.1016/j.nicl.2018.06.020. eCollection 2018.

26.

Prosodic and phonetic subtypes of primary progressive apraxia of speech.

Utianski RL, Duffy JR, Clark HM, Strand EA, Botha H, Schwarz CG, Machulda MM, Senjem ML, Spychalla AJ, Jack CR Jr, Petersen RC, Lowe VJ, Whitwell JL, Josephs KA.

Brain Lang. 2018 Sep;184:54-65. doi: 10.1016/j.bandl.2018.06.004. Epub 2018 Jul 4.

27.

Tau uptake in agrammatic primary progressive aphasia with and without apraxia of speech.

Utianski RL, Whitwell JL, Schwarz CG, Duffy JR, Botha H, Clark HM, Machulda MM, Senjem ML, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA.

Eur J Neurol. 2018 Nov;25(11):1352-1357. doi: 10.1111/ene.13733. Epub 2018 Jul 26.

PMID:
29935044
28.

18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus.

Townley RA, Botha H, Graff-Radford J, Boeve BF, Petersen RC, Senjem ML, Knopman DS, Lowe V, Jack CR Jr, Jones DT.

Neuroimage Clin. 2018 Feb 28;18:897-902. doi: 10.1016/j.nicl.2018.02.031. eCollection 2018.

29.

Non-right handed primary progressive apraxia of speech.

Botha H, Duffy JR, Whitwell JL, Strand EA, Machulda MM, Spychalla AJ, Tosakulwong N, Senjem ML, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA.

J Neurol Sci. 2018 Jul 15;390:246-254. doi: 10.1016/j.jns.2018.05.007. Epub 2018 May 7.

30.

Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration.

Tetzloff KA, Duffy JR, Strand EA, Machulda MM, Boland SM, Utianski RL, Botha H, Senjem ML, Schwarz CG, Josephs KA, Whitwell JL.

Neurocase. 2018 Apr;24(2):111-120. doi: 10.1080/13554794.2018.1477963. Epub 2018 May 25.

31.

Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants.

Lowe VJ, Bruinsma TJ, Min HK, Lundt ES, Fang P, Senjem ML, Boeve BF, Josephs KA, Pandey MK, Murray ME, Kantarci K, Jones DT, Schwarz CG, Knopman DS, Petersen RC, Jack CR Jr.

Alzheimers Dement (Amst). 2018 Feb 7;10:210-216. doi: 10.1016/j.dadm.2018.01.005. eCollection 2018.

32.

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values.

Schwarz CG, Tosakulwong N, Senjem ML, Gunter JL, Therneau TM, Vemuri P, Lowe VJ, Jack CR Jr.

Sci Rep. 2018 May 9;8(1):7421. doi: 10.1038/s41598-018-25459-9.

33.

White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition.

Lowe VJ, Lundt ES, Senjem ML, Schwarz CG, Min HK, Przybelski SA, Kantarci K, Knopman D, Petersen RC, Jack CR Jr.

J Nucl Med. 2018 Oct;59(10):1583-1589. doi: 10.2967/jnumed.117.204271. Epub 2018 Apr 19.

34.

Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.

Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Lowe VJ, Fields JA, Gunter JL, Senjem ML, Settell ML, Gleason CE, Shuster LT, Bailey KR, Dowling NM, Asthana S, Jack CR Jr, Rocca WA, Miller VM.

Neurology. 2018 Apr 17;90(16):e1404-e1412. doi: 10.1212/WNL.0000000000005325. Epub 2018 Mar 21.

35.

Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.

Tetzloff KA, Graff-Radford J, Martin PR, Tosakulwong N, Machulda MM, Duffy JR, Clark HM, Senjem ML, Schwarz CG, Spychalla AJ, Drubach DA, Jack CR, Lowe VJ, Josephs KA, Whitwell JL.

J Alzheimers Dis. 2018;62(4):1713-1724. doi: 10.3233/JAD-170740.

36.

Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.

Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda MM, Senjem ML, Spychalla AJ, Vemuri P, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA.

Alzheimers Dement. 2018 Aug;14(8):1005-1014. doi: 10.1016/j.jalz.2018.02.020. Epub 2018 Mar 30.

37.

Longitudinal tau PET in ageing and Alzheimer's disease.

Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, Machulda MM, Petersen RC.

Brain. 2018 May 1;141(5):1517-1528. doi: 10.1093/brain/awy059.

38.

[18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation.

Ali F, Whitwell JL, Martin PR, Senjem ML, Knopman DS, Jack CR, Lowe VJ, Petersen RC, Boeve BF, Josephs KA.

J Neurol. 2018 May;265(5):1079-1088. doi: 10.1007/s00415-018-8815-x. Epub 2018 Mar 1.

39.

Joint associations of β-amyloidosis and cortical thickness with cognition.

Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC, Jack CR Jr.

Neurobiol Aging. 2018 May;65:121-131. doi: 10.1016/j.neurobiolaging.2018.01.017. Epub 2018 Feb 2.

40.

[18 F]AV-1451 tau-PET and primary progressive aphasia.

Josephs KA, Martin PR, Botha H, Schwarz CG, Duffy JR, Clark HM, Machulda MM, Graff-Radford J, Weigand SD, Senjem ML, Utianski RL, Drubach DA, Boeve BF, Jones DT, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Whitwell JL.

Ann Neurol. 2018 Mar;83(3):599-611. doi: 10.1002/ana.25183. Epub 2018 Mar 13.

41.

In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.

Jones DT, Knopman DS, Graff-Radford J, Syrjanen JA, Senjem ML, Schwarz CG, Dheel C, Wszolek Z, Rademakers R, Kantarci K, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF.

Neurology. 2018 Mar 13;90(11):e947-e954. doi: 10.1212/WNL.0000000000005117. Epub 2018 Feb 9.

42.

Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.

Botha H, Mantyh WG, Graff-Radford J, Machulda MM, Przybelski SA, Wiste HJ, Senjem ML, Parisi JE, Petersen RC, Murray ME, Boeve BF, Lowe VJ, Knopman DS, Jack CR Jr, Jones DT.

Neurology. 2018 Mar 13;90(11):e940-e946. doi: 10.1212/WNL.0000000000005124. Epub 2018 Feb 7.

43.

Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.

Utianski RL, Whitwell JL, Schwarz CG, Senjem ML, Tosakulwong N, Duffy JR, Clark HM, Machulda MM, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA.

Cortex. 2018 Feb;99:358-374. doi: 10.1016/j.cortex.2017.12.021. Epub 2018 Jan 2.

44.

[18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.

Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, Schwarz CG, Spychalla AJ, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA.

Ann Neurol. 2018 Feb;83(2):248-257. doi: 10.1002/ana.25142. Epub 2018 Feb 6.

45.

Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.

Whitwell JL, Ahlskog JE, Tosakulwong N, Senjem ML, Spychalla AJ, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA.

Parkinsonism Relat Disord. 2018 Mar;48:3-9. doi: 10.1016/j.parkreldis.2017.12.016. Epub 2017 Dec 13.

46.

Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.

Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.

Brain. 2018 Jan 1;141(1):271-287. doi: 10.1093/brain/awx320.

47.

Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.

Tetzloff KA, Duffy JR, Clark HM, Strand EA, Machulda MM, Schwarz CG, Senjem ML, Reid RI, Spychalla AJ, Tosakulwong N, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL.

Brain. 2018 Jan 1;141(1):302-317. doi: 10.1093/brain/awx293.

48.

Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.

Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, Botha H, Kantarci K, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Cortex. 2017 Dec;97:143-159. doi: 10.1016/j.cortex.2017.09.018. Epub 2017 Oct 3.

49.

Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech.

Whitwell JL, Weigand SD, Duffy JR, Clark HM, Strand EA, Machulda MM, Spychalla AJ, Senjem ML, Jack CR Jr, Josephs KA.

Neurology. 2017 Nov 28;89(22):2271-2279. doi: 10.1212/WNL.0000000000004685. Epub 2017 Nov 1.

50.

Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.

Josephs KA, Dickson DW, Tosakulwong N, Weigand SD, Murray ME, Petrucelli L, Liesinger AM, Senjem ML, Spychalla AJ, Knopman DS, Parisi JE, Petersen RC, Jack CR Jr, Whitwell JL.

Lancet Neurol. 2017 Nov;16(11):917-924. doi: 10.1016/S1474-4422(17)30284-3. Epub 2017 Sep 11.

Supplemental Content

Loading ...
Support Center